Business Wire: Pulse Biosciences to Present New Data on Nano-Pulse Stimulation Procedure for Sebaceous Hyperplasia and for Focal Epithelial Hyperplasia at 2022 American Society of Laser ... Pulse Biosciences to Present New Data on Nano-Pulse Stimulation Procedure for Sebaceous Hyperplasia and for Focal Epithelial Hyperplasia at 2022 American Society of Laser ... (RTTNews) - Pulse Biosciences, Inc.
(PLSE), a bioelectric medicine company, has received FDA clearance for its CellFX System to expand the indication for use in the treatment of sebaceous hyperplasia ... Generally the result of age- related decreases in androgen production, sebaceous hyperplasia is characterized by common asymptomatic papules. The condition occurs most frequently in healthy ... Healio: FDA expands indication of CellFX System to include patients with sebaceous hyperplasia FDA expands indication of CellFX System to include patients with sebaceous hyperplasia Nasdaq: Pulse Biosciences Announces FDA 510(k) Clearance for the Treatment of Sebaceous Hyperplasia Pulse Biosciences Announces FDA 510(k) Clearance for the Treatment of Sebaceous Hyperplasia
